Published in Diabetes Care on September 15, 2009
Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol (2011) 2.44
Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care (2010) 2.22
A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology (2012) 2.21
High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One (2012) 2.17
Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol (2010) 1.87
Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. Am J Clin Nutr (2010) 1.85
Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care (2010) 1.61
The vagus nerve and the inflammatory reflex--linking immunity and metabolism. Nat Rev Endocrinol (2012) 1.59
Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity. J Am Coll Cardiol (2011) 1.57
A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care (2010) 1.52
Retracted Physical exercise reduces circulating lipopolysaccharide and TLR4 activation and improves insulin signaling in tissues of DIO rats. Diabetes (2011) 1.50
TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. J Clin Endocrinol Metab (2010) 1.48
Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity (Silver Spring) (2010) 1.47
Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes. Diabetes Care (2012) 1.46
A dose-response strategy reveals differences between normal-weight and obese men in their metabolic and inflammatory responses to a high-fat meal. J Nutr (2014) 1.45
Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors. Am J Physiol Endocrinol Metab (2010) 1.45
Fractalkine is a novel human adipochemokine associated with type 2 diabetes. Diabetes (2011) 1.44
High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects. Diabetes Care (2011) 1.43
A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease. Aliment Pharmacol Ther (2015) 1.41
A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J Clin Endocrinol Metab (2011) 1.35
Subcutaneous adipose tissue macrophage infiltration is associated with hepatic and visceral fat deposition, hyperinsulinemia, and stimulation of NF-κB stress pathway. Diabetes (2011) 1.24
Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr Opin Clin Nutr Metab Care (2011) 1.19
Systemic inflammation and the metabolic syndrome among middle-aged community volunteers. Metabolism (2010) 1.16
Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? J Obes (2012) 1.16
Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity. PLoS One (2013) 1.15
Of microbes and meals: the health consequences of dietary endotoxemia. Nutr Clin Pract (2012) 1.10
Macrophages, meta-inflammation, and immuno-metabolism. ScientificWorldJournal (2011) 1.10
Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med (2016) 1.08
Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver. World J Gastroenterol (2011) 1.07
Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease. World J Gastroenterol (2014) 1.07
Plasma metabolomics and proteomics profiling after a postprandial challenge reveal subtle diet effects on human metabolic status. Metabolomics (2011) 1.06
Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci (2015) 1.06
Gut microbiota, probiotics and diabetes. Nutr J (2014) 1.06
Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: evidence from bariatric surgery. Diabetes Care (2013) 1.05
High glucose concentrations induce TNF-α production through the down-regulation of CD33 in primary human monocytes. BMC Immunol (2012) 1.03
Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications. Metabolism (2010) 1.02
Effect of lipopolysaccharide on inflammation and insulin action in human muscle. PLoS One (2013) 0.99
Reduction in inflammation and the expression of amyloid precursor protein and other proteins related to Alzheimer's disease following gastric bypass surgery. J Clin Endocrinol Metab (2012) 0.99
Macronutrient intake induces oxidative and inflammatory stress: potential relevance to atherosclerosis and insulin resistance. Exp Mol Med (2010) 0.96
Reduced Socs3 expression in adipose tissue protects female mice against obesity-induced insulin resistance. Diabetologia (2012) 0.94
Tetrahydro iso-alpha acids from hops improve glucose homeostasis and reduce body weight gain and metabolic endotoxemia in high-fat diet-fed mice. PLoS One (2012) 0.93
Role of inflammasome activation in the pathophysiology of vascular diseases of the neurovascular unit. Antioxid Redox Signal (2014) 0.92
Nutrition facts in multiple sclerosis. ASN Neuro (2015) 0.91
Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. Clin Biochem (2015) 0.91
Recurrent exposure to subclinical lipopolysaccharide increases mortality and induces cardiac fibrosis in mice. PLoS One (2013) 0.90
The endothelial cell: an "early responder" in the development of insulin resistance. Rev Endocr Metab Disord (2013) 0.90
Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability. Front Immunol (2015) 0.90
Fast food fever: reviewing the impacts of the Western diet on immunity. Nutr J (2014) 0.89
Altered response of skeletal muscle to IL-6 in type 2 diabetic patients. Diabetes (2012) 0.89
Induction of cytosolic phospholipase a2α is required for adipose neutrophil infiltration and hepatic insulin resistance early in the course of high-fat feeding. Diabetes (2013) 0.89
Myocardial fibrosis induced by exposure to subclinical lipopolysaccharide is associated with decreased miR-29c and enhanced NOX2 expression in mice. PLoS One (2014) 0.89
The role of fatty acids in insulin resistance. Lipids Health Dis (2015) 0.88
Functional metagenomic investigations of the human intestinal microbiota. Front Microbiol (2011) 0.88
Low levels of lipopolysaccharide modulate mitochondrial oxygen consumption in skeletal muscle. Metabolism (2014) 0.88
Dietary oil composition differentially modulates intestinal endotoxin transport and postprandial endotoxemia. Nutr Metab (Lond) (2013) 0.87
Diet and aging. Oxid Med Cell Longev (2012) 0.86
Amelioration in wound healing in diabetic toll-like receptor-4 knockout mice. J Diabetes Complications (2013) 0.84
Early skeletal muscle adaptations to short-term high-fat diet in humans before changes in insulin sensitivity. Obesity (Silver Spring) (2015) 0.83
Comparison with ancestral diets suggests dense acellular carbohydrates promote an inflammatory microbiota, and may be the primary dietary cause of leptin resistance and obesity. Diabetes Metab Syndr Obes (2012) 0.83
Evidence for metabolic endotoxemia in obese and diabetic Gambian women. Nutr Diabetes (2013) 0.82
Effects of pregnancy on obesity-induced inflammation in a mouse model of fetal programming. Int J Obes (Lond) (2014) 0.82
Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulation. FEMS Microbiol Ecol (2013) 0.81
Profiles of Microbial Fatty Acids in the Human Metabolome are Disease-Specific. Front Microbiol (2011) 0.81
Effects of dyslipidaemia on monocyte production and function in cardiovascular disease. Nat Rev Cardiol (2017) 0.81
You deserve what you eat: lessons learned from the study of the melanin-concentrating hormone (MCH)-deficient mice. Gut (2010) 0.80
Patients with type 1 diabetes show signs of vascular dysfunction in response to multiple high-fat meals. Nutr Metab (Lond) (2014) 0.80
Elevated serum levels of interleukin-18 in patients with overt diabetic nephropathy: effects of miglitol. Clin Exp Nephrol (2010) 0.80
Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS). Oncotarget (2015) 0.80
Gut Microbiota and Lifestyle Interventions in NAFLD. Int J Mol Sci (2016) 0.79
Hyperlipidemia modifies innate immune responses to lipopolysaccharide via the TLR-NF-κB signaling pathway. Inflammation (2013) 0.79
Addition of a dairy fraction rich in milk fat globule membrane to a high-saturated fat meal reduces the postprandial insulinaemic and inflammatory response in overweight and obese adults. J Nutr Sci (2016) 0.79
Neutrophil functions in morbidly obese subjects. Clin Exp Immunol (2015) 0.78
Lipoic acid attenuates innate immune infiltration and activation in the visceral adipose tissue of obese insulin resistant mice. Lipids (2011) 0.78
Lipopolysaccharide-induced loss of cultured rat myenteric neurons - role of AMP-activated protein kinase. PLoS One (2014) 0.78
Gut microbiota and sirtuins in obesity-related inflammation and bowel dysfunction. J Transl Med (2011) 0.77
A Randomized Controlled Trial to Increase Navy Bean or Rice Bran Consumption in Colorectal Cancer Survivors. Nutr Cancer (2016) 0.77
Gut microbiota and Ma-Pi 2 macrobiotic diet in the treatment of type 2 diabetes. World J Diabetes (2015) 0.77
Recent advances in pathogenesis, assessment, and treatment of atherosclerosis. F1000Res (2016) 0.77
Lipopolysaccharide-binding protein plasma levels as a biomarker of obesity-related insulin resistance in adolescents. Korean J Pediatr (2016) 0.77
Obesity-associated cancer risk: the role of intestinal microbiota in the etiology of the host proinflammatory state. Transl Res (2016) 0.77
Resveratrol and diabetes. Rev Diabet Stud (2014) 0.77
Effects of red wine on postprandial stress: potential implication in non-alcoholic fatty liver disease development. Eur J Nutr (2015) 0.77
Effects of meal composition on postprandial incretin, glucose and insulin responses after surgical and medical weight loss. Obes Sci Pract (2015) 0.76
Cranberry extract attenuates hepatic inflammation in high-fat-fed obese mice. J Nutr Biochem (2016) 0.76
Weight gain as a consequence of living a modern lifestyle: a discussion of barriers to effective weight control and how to overcome them. J Chiropr Humanit (2013) 0.75
Dietary cholesterol and egg yolk should be avoided by patients at risk of vascular disease. J Transl Int Med (2016) 0.75
Macronutrient intake, insulin secretion, oxidative stress & inflammation: Clinico-pathological implications. Indian J Med Res (2016) 0.75
Meal rich in carbohydrate, but not protein or fat, reveals adverse immunometabolic responses associated with obesity. Nutr J (2016) 0.75
Intestinal alkaline phosphatase deficiency leads to lipopolysaccharide desensitization and faster weight gain. Infect Immun (2014) 0.75
Comment on: Lassenius et al. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care 2011;34:1809-1815. Diabetes Care (2012) 0.75
Dyslipidemia rather than Type 2 Diabetes Mellitus or Chronic Periodontitis Affects the Systemic Expression of Pro- and Anti-Inflammatory Genes. Mediators Inflamm (2017) 0.75
Human Intestinal Barrier Function in Health and Disease. Clin Transl Gastroenterol (2016) 0.75
Dietary Factors Reduce Risk of Acute Pancreatitis in a Large Multiethnic Cohort. Clin Gastroenterol Hepatol (2016) 0.75
Magnitude and Timing of the Postprandial Inflammatory Response to a High-Fat Meal in Healthy Adults: A Systematic Review. Adv Nutr (2017) 0.75
Acute-phase proteins and incidence of diabetes: a population-based cohort study. Acta Diabetol (2016) 0.75
Comparisons of the Postprandial Inflammatory and Endotoxaemic Responses to Mixed Meals in Young and Older Individuals: A Randomised Trial. Nutrients (2017) 0.75
Acute low-dose endotoxin treatment results in improved whole-body glucose homeostasis in mice. Metabolism (2016) 0.75
Uniting Epidemiology and Experimental Disease Models for Alcohol-Related Pancreatic Disease. Alcohol Res (2017) 0.75
Macrophage functions in lean and obese adipose tissue. Metabolism (2017) 0.75
TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest (2006) 17.49
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes (2008) 10.74
Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol (2004) 6.78
Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation (2005) 4.17
Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab (2006) 3.84
Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation (2002) 3.60
Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation (2004) 3.17
Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation (2001) 3.15
Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab (2001) 3.05
Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab (2007) 2.84
The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem (1999) 2.63
Role of Toll-like receptors in pathogen recognition. Clin Microbiol Rev (2003) 2.59
Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc Natl Acad Sci U S A (2004) 2.54
High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes (2008) 2.23
Acute modulation of toll-like receptors by insulin. Diabetes Care (2008) 1.46
Orange juice or fructose intake does not induce oxidative and inflammatory response. Diabetes Care (2007) 1.46
Role of inflammatory mediators in the suppression of insulin receptor phosphorylation in circulating mononuclear cells of obese subjects. Diabetologia (2006) 1.42
Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet. J Endocrinol (2008) 1.41
Prolonged reactive oxygen species generation and nuclear factor-kappaB activation after a high-fat, high-carbohydrate meal in the obese. J Clin Endocrinol Metab (2007) 1.38
Toll-like receptors as sensors of pathogens. Pediatr Res (2001) 1.26
Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability-increasing protein. Diabetes (2006) 1.24
Enhanced peripheral vasodilation in humans after a fatty meal. J Am Coll Cardiol (2000) 1.16
A rapid, specific assay for superoxide release from phagocytes in small volumes of whole blood. Am J Clin Pathol (1992) 0.96
Chronic systemic inflammation in overweight and obese adults. JAMA (2000) 0.91
Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation (2005) 4.17
Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation (2004) 3.17
Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes (2003) 3.00
Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab (2004) 2.93
Evidence for a potent antiinflammatory effect of rosiglitazone. J Clin Endocrinol Metab (2004) 2.36
Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke (2005) 2.24
Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. Am J Clin Nutr (2010) 1.85
Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care (2010) 1.61
Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care (2010) 1.60
Increase in intranuclear nuclear factor kappaB and decrease in inhibitor kappaB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect. Am J Clin Nutr (2004) 1.57
Sitagliptin exerts an antinflammatory action. J Clin Endocrinol Metab (2012) 1.55
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF TESTOSTERONE AND CARDIOVASCULAR RISK. Endocr Pract (2015) 1.52
An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol. J Clin Endocrinol Metab (2010) 1.48
Acute modulation of toll-like receptors by insulin. Diabetes Care (2008) 1.46
Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation (2004) 1.46
Orange juice or fructose intake does not induce oxidative and inflammatory response. Diabetes Care (2007) 1.46
Insulin as an anti-inflammatory and antiatherogenic modulator. J Am Coll Cardiol (2009) 1.43
Rosiglitazone, thiazolidinediones and atherosclerosis. Atherosclerosis (2010) 1.41
Prolonged reactive oxygen species generation and nuclear factor-kappaB activation after a high-fat, high-carbohydrate meal in the obese. J Clin Endocrinol Metab (2007) 1.38
Exenatide exerts a potent antiinflammatory effect. J Clin Endocrinol Metab (2011) 1.37
Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J Clin Endocrinol Metab (2002) 1.35
Exenatide therapy in obese patients with type 2 diabetes mellitus treated with insulin. Endocr Pract (2007) 1.35
A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes. Diabetes Care (2002) 1.35
A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J Clin Endocrinol Metab (2011) 1.35
Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J Clin Endocrinol Metab (2004) 1.34
Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease. Am J Cardiol (2006) 1.23
Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer. Clin Chem (2009) 1.20
Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr (2002) 1.19
Contrasting testosterone concentrations in type 1 and type 2 diabetes. Diabetes Care (2006) 1.18
Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-kappaB in mononuclear cells. Metabolism (2004) 1.17
Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9. Diabetes Care (2003) 1.16
Liraglutide as additional treatment for type 1 diabetes. Eur J Endocrinol (2011) 1.15
Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes. J Clin Endocrinol Metab (2003) 1.13
Testosterone concentration in young patients with diabetes. Diabetes Care (2008) 1.11
Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes. Diabetes Care (2006) 1.11
Insulin infusion in acute illness. J Clin Invest (2005) 1.10
Anti-inflammatory effects of insulin. Curr Opin Clin Nutr Metab Care (2007) 1.10
The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes. J Clin Endocrinol Metab (2003) 1.08
Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics. J Clin Endocrinol Metab (2006) 1.04
Suppressive effect of insulin infusion on chemokines and chemokine receptors. Diabetes Care (2010) 1.03
Endothelial dysfunction, inflammation and diabetes. Rev Endocr Metab Disord (2004) 1.03
Fatty acid synthase activity regulates HER2 extracellular domain shedding into the circulation of HER2-positive metastatic breast cancer patients. Int J Oncol (2009) 1.01
Durability of effects of exenatide treatment on glycemic control, body weight, systolic blood pressure, C-reactive protein, and triglyceride concentrations. Endocr Pract (2011) 1.01
Comparative evaluation of adjunctive oral irrigation in diabetics. J Clin Periodontol (2002) 1.00
Prediction of adverse outcomes by blood glucose level after endovascular therapy for acute ischemic stroke. J Neurosurg (2011) 1.00
Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome. Curr Mol Med (2008) 1.00
Reduction in inflammation and the expression of amyloid precursor protein and other proteins related to Alzheimer's disease following gastric bypass surgery. J Clin Endocrinol Metab (2012) 0.99
A high-carbohydrate diet in the immediate postnatal life of rats induces adaptations predisposing to adult-onset obesity. J Endocrinol (2008) 0.98
Macronutrient intake induces oxidative and inflammatory stress: potential relevance to atherosclerosis and insulin resistance. Exp Mol Med (2010) 0.96
Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells. Metabolism (2002) 0.95
Insulin increases reendothelialization and inhibits cell migration and neointimal growth after arterial injury. Arterioscler Thromb Vasc Biol (2009) 0.95
Cardiovascular benefits of exogenous insulin. J Clin Endocrinol Metab (2012) 0.95
Testosterone concentrations in young pubertal and post-pubertal obese males. Clin Endocrinol (Oxf) (2013) 0.94
Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes. Diabetes Care (2003) 0.93
Liraglutide as additional treatment to insulin in obese patients with type 1 diabetes mellitus. Endocr Pract (2013) 0.93
Low estradiol concentrations in men with subnormal testosterone concentrations and type 2 diabetes. Diabetes Care (2011) 0.93
Insulin suppresses endotoxin-induced oxidative, nitrosative, and inflammatory stress in humans. Diabetes Care (2010) 0.92
Proinflammatory and prothrombotic effects of hypoglycemia. Diabetes Care (2010) 0.91
The effects of hypogonadism on body composition and bone mineral density in type 2 diabetic patients. Diabetes Care (2007) 0.91